Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 April 2023 | Story Anathi Nyadu and Avela Ntsongelwa | Photo Supplied
Humanities Soutpan community outreach
Collaborating to uplift the community of Soutpan. Staff members from the Faculty of the Humanities met with representatives of the Soutpan community to engage in community-enriching projects.

Universities have an important role to play in the healing of communities by engaging in initiatives that address social ills such as drug abuse, teenage pregnancy, violence against children, women, and the elderly. 

This is according to Prof Mogomme Masoga, Dean of the Faculty of the Humanities at the University of the Free State (UFS). Prof Masoga was addressing guests, including faculty staff members and community members of Soutpan, at the launch (18 April 2023) of the faculty’s community engagement partnership with the community of Ikgomotseng in Soutpan, some 40 km outside Bloemfontein.  He informed guests that the partnership was the first of many initiatives that the faculty will be engaging in with the community of Soutpan.

Flagship partnership 

The flagship partnership will see participation by various departments within the faculty, including a parenting project with carers at day-care centres and in the communities, led by students from the Department of Psychology. The Department of Drama and Theatre Arts will stimulate the children’s minds through puppet shows, while the Department of History will collaborate with the community on heritage issues. During the engagement with the community, the Department of Sociology also indicated that it is launching an engaged scholarship month project for their honours and second-year Social Movements modules, where several guest lecturers will engage with students to bring stronger social context to sociological discussion. The faculty is also exploring a literacy project where it will contribute books and inculcate a culture of reading among community members.

Talking about the origin of the collaborative engagement, Dr Rosaline Sebolao, Teaching and Learning Manager in the faculty, says “the partnership emanated from a visit by the faculty to a day-care centre called Halaletsang, founded by a community leader, Belina Nhlapo, who demonstrated her passion for empowering communities. With the intention of expanding the faculty’s engaged scholarship programme, the team entered into a number of engagements that led to the identification of potential collaborative projects by departments and the community”.

Maximum societal impact with sustainable relationships

This partnership is one way in which the Faculty of the Humanities hopes to contribute to the UFS’Vision 130. The faculty aims to bring Vision 130 to reality by conducting community research and establishing quality relationships that will yield sustainable results. These results will not only impact communities but also our students who, through their engagement, will become globally competent and competitive graduates. 

According to Israel Mawoyo, First-Year Success Programme (FYSP) coordinator in the faculty, the partnerships involve a working relationship for the Faculty of the Humanities and the community of Soutpan. “This partnership will create a platform for staff and students to engage in the scholarship of community engagement practices within the community. Ultimately, the Soutpan and the faculty community are to work together so that they both benefit from this partnership.”

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept